Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Leveraging a Biomanufacturing Legacy to Support New Business | Contract Pharma
Literature / Brochures

Leveraging a Biomanufacturing Legacy to Support New Business

A sit down with six diverse experts at Grifols Recombinant Protein CDMO.

Grifols Recombinant Protein Contract Development and Manufacturing Organization (CDMO) has three decades of experience manufacturing recombinant proteins. Recently, the business expanded its focus to apply its experience to producing therapeutic proteins for biopharmaceutical organizations. Its new GMP consolidated manufacturing facility (CMF) on its Emeryville, California, campus supports this expansion.

The CMF facility houses multiproduct production and features state-of-the-art equipment, including a distributed control system and a central data historian. We sat down with six diverse experts at Grifols Recombinant Protein CDMO to discuss how the group’s legacy and recent investments support its future in providing recombinant protein CDMO services.

READ MORE BY FILLING OUT THE FORM >>>>>

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters